Nanomedicines
Advancing nanomedicine development for targeted drug delivery and next-generation therapies.
Get to market faster with CPI
At CPI, we support the development, optimisation, and scale-up of nanomedicines, helping you harness nano-formulations for enhanced drug delivery, improved stability, and therapeutic efficacy.
Our expertise in nanoparticle synthesis, formulation development, and analytical characterisation ensures your innovations meet the highest standards of safety, quality, and performance. Whether working with lipid nanoparticles (LNPs), polymeric carriers, or other targeted drug delivery systems, we provide the tools and infrastructure to accelerate your journey from preclinical research to clinical application.
Nanomedicines
Advancing nanomedicine development for targeted drug delivery and next-generation therapies.
Get to market faster with CPI
At CPI, we support the development, optimisation, and scale-up of nanomedicines, helping you harness nano-formulations for enhanced drug delivery, improved stability, and therapeutic efficacy.
Our expertise in nanoparticle synthesis, formulation development, and analytical characterisation ensures your innovations meet the highest standards of safety, quality, and performance. Whether working with lipid nanoparticles (LNPs), polymeric carriers, or other targeted drug delivery systems, we provide the tools and infrastructure to accelerate your journey from preclinical research to clinical application.
Nanomedicines
Advancing nanomedicine development for targeted drug delivery and next-generation therapies.
Get to market faster with CPI
At CPI, we support the development, optimisation, and scale-up of nanomedicines, helping you harness nano-formulations for enhanced drug delivery, improved stability, and therapeutic efficacy.
Our expertise in nanoparticle synthesis, formulation development, and analytical characterisation ensures your innovations meet the highest standards of safety, quality, and performance. Whether working with lipid nanoparticles (LNPs), polymeric carriers, or other targeted drug delivery systems, we provide the tools and infrastructure to accelerate your journey from preclinical research to clinical application.
What we offer
Whether you need technical expertise, lab-based development, or process optimisation, our tailored approach ensures you have the right support at every stage.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
Nanomedicine process development and optimisation
Accelerate your nanomedicine innovation with our comprehensive formulation and process development support:
Formulation development for active payloads, delivery systems, and excipient selection.
Screening for enhanced stability, targeted delivery, and sustained release.
Batch and continuous manufacturing of nanoparticle formulations.
Solvent removal, buffer exchange, isolation, lyophilisation, and concentration.
High-throughput formulation screening and characterisation.
Tech transfer support for seamless scale-up.
Digital modelling to optimise process parameters and predict product quality.
These capabilities ensure robust, scalable, and high-performance nanomedicine development.
Analytical method development and stability testing
Ensure the quality, integrity, and stability of your nanomedicines with our analytical expertise:
Particle size, surface charge, and morphology analysis (DLS, SEM, AFM).
Chemical composition assessment (HPLC, GC, FT-IR, Raman spectroscopy).
Drug loading, release kinetics, and bioavailability studies.
Pharmacopoeial testing for regulatory alignment.
Real-time and accelerated stability studies (-80°C to 100°C).
Data-driven insights to inform formulation refinement and shelf-life prediction.
These capabilities de-risk development and support product quality throughout the lifecycle.
Preclinical material supply for in vitro and in vivo testing
Support preclinical and clinical progression with expert material production:
Low-bioburden and endotoxin-free nanomedicine formulations.
Scalable supply for in vitro and in vivo studies.
Process robustness for clinical readiness.
Documentation and tech transfer support for GMP compliance.
In vitro and in vivo screening via the Intracellular Drug Delivery Centre.
GMP manufacturing capability via our RNA Centre of Excellence for clinical trial supply.
These capabilities ensure a smooth transition from discovery to clinical trials.
What we offer
Whether you need technical expertise, lab-based development, or process optimisation, our tailored approach ensures you have the right support at every stage.
Nanomedicine process development and optimisation
Accelerate your nanomedicine innovation with our comprehensive formulation and process development support:
Formulation development for active payloads, delivery systems, and excipient selection.
Screening for enhanced stability, targeted delivery, and sustained release.
Batch and continuous manufacturing of nanoparticle formulations.
Solvent removal, buffer exchange, isolation, lyophilisation, and concentration.
High-throughput formulation screening and characterisation.
Tech transfer support for seamless scale-up.
Digital modelling to optimise process parameters and predict product quality.
These capabilities ensure robust, scalable, and high-performance nanomedicine development.
Analytical method development and stability testing
Ensure the quality, integrity, and stability of your nanomedicines with our analytical expertise:
Particle size, surface charge, and morphology analysis (DLS, SEM, AFM).
Chemical composition assessment (HPLC, GC, FT-IR, Raman spectroscopy).
Drug loading, release kinetics, and bioavailability studies.
Pharmacopoeial testing for regulatory alignment.
Real-time and accelerated stability studies (-80°C to 100°C).
Data-driven insights to inform formulation refinement and shelf-life prediction.
These capabilities de-risk development and support product quality throughout the lifecycle.
Preclinical material supply for in vitro and in vivo testing
Support preclinical and clinical progression with expert material production:
Low-bioburden and endotoxin-free nanomedicine formulations.
Scalable supply for in vitro and in vivo studies.
Process robustness for clinical readiness.
Documentation and tech transfer support for GMP compliance.
In vitro and in vivo screening via the Intracellular Drug Delivery Centre.
GMP manufacturing capability via our RNA Centre of Excellence for clinical trial supply.
These capabilities ensure a smooth transition from discovery to clinical trials.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
What we offer
Whether you need technical expertise, lab-based development, or process optimisation, our tailored approach ensures you have the right support at every stage.
Nanomedicine process development and optimisation
Accelerate your nanomedicine innovation with our comprehensive formulation and process development support:
Formulation development for active payloads, delivery systems, and excipient selection.
Screening for enhanced stability, targeted delivery, and sustained release.
Batch and continuous manufacturing of nanoparticle formulations.
Solvent removal, buffer exchange, isolation, lyophilisation, and concentration.
High-throughput formulation screening and characterisation.
Tech transfer support for seamless scale-up.
Digital modelling to optimise process parameters and predict product quality.
These capabilities ensure robust, scalable, and high-performance nanomedicine development.
Analytical method development and stability testing
Ensure the quality, integrity, and stability of your nanomedicines with our analytical expertise:
Particle size, surface charge, and morphology analysis (DLS, SEM, AFM).
Chemical composition assessment (HPLC, GC, FT-IR, Raman spectroscopy).
Drug loading, release kinetics, and bioavailability studies.
Pharmacopoeial testing for regulatory alignment.
Real-time and accelerated stability studies (-80°C to 100°C).
Data-driven insights to inform formulation refinement and shelf-life prediction.
These capabilities de-risk development and support product quality throughout the lifecycle.
Preclinical material supply for in vitro and in vivo testing
Support preclinical and clinical progression with expert material production:
Low-bioburden and endotoxin-free nanomedicine formulations.
Scalable supply for in vitro and in vivo studies.
Process robustness for clinical readiness.
Documentation and tech transfer support for GMP compliance.
In vitro and in vivo screening via the Intracellular Drug Delivery Centre.
GMP manufacturing capability via our RNA Centre of Excellence for clinical trial supply.
These capabilities ensure a smooth transition from discovery to clinical trials.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
What we offer
Whether you need technical expertise, lab-based development, or process optimisation, our tailored approach ensures you have the right support at every stage.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
Nanomedicine process development and optimisation
Accelerate your nanomedicine innovation with our comprehensive formulation and process development support:
Formulation development for active payloads, delivery systems, and excipient selection.
Screening for enhanced stability, targeted delivery, and sustained release.
Batch and continuous manufacturing of nanoparticle formulations.
Solvent removal, buffer exchange, isolation, lyophilisation, and concentration.
High-throughput formulation screening and characterisation.
Tech transfer support for seamless scale-up.
Digital modelling to optimise process parameters and predict product quality.
These capabilities ensure robust, scalable, and high-performance nanomedicine development.
Analytical method development and stability testing
Ensure the quality, integrity, and stability of your nanomedicines with our analytical expertise:
Particle size, surface charge, and morphology analysis (DLS, SEM, AFM).
Chemical composition assessment (HPLC, GC, FT-IR, Raman spectroscopy).
Drug loading, release kinetics, and bioavailability studies.
Pharmacopoeial testing for regulatory alignment.
Real-time and accelerated stability studies (-80°C to 100°C).
Data-driven insights to inform formulation refinement and shelf-life prediction.
These capabilities de-risk development and support product quality throughout the lifecycle.
Preclinical material supply for in vitro and in vivo testing
Support preclinical and clinical progression with expert material production:
Low-bioburden and endotoxin-free nanomedicine formulations.
Scalable supply for in vitro and in vivo studies.
Process robustness for clinical readiness.
Documentation and tech transfer support for GMP compliance.
In vitro and in vivo screening via the Intracellular Drug Delivery Centre.
GMP manufacturing capability via our RNA Centre of Excellence for clinical trial supply.
These capabilities ensure a smooth transition from discovery to clinical trials.
Nanomedicines
applications
We enable innovation across a wide range of nanomedicine applications.
Lipid nanoparticle (LNPs) delivery systems.
Targeted drug delivery.
Nano-formulated vaccines.
Controlled release therapeutics.
Cancer nanomedicines.
Nanoparticle diagnostics.
How we support you
From discovery to commercialisation, we enable scalable, cost-effective, regulatory-compliant, and environmentally conscious pharmaceutical innovations.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
Demonstrate the benefits of your nanomedicine innovation
Accelerate early-stage development and build investor confidence with:
Rapid, cost-effective proof-of-concept studies.
Testing of nano-formulations in industry-relevant conditions.
Optimisation of nano-based drug delivery systems for performance and stability.
Prove manufacturability and scalability
De-risk scale-up through:
Manufacturability assessments of nanoparticle formulations.
Optimisation for yield, reproducibility, stability, and cost efficiency.
Integration of continuous processes and automation for clinical and commercial readiness.
Assess and demonstrate commercial viability
Gain the insight and evidence you need to unlock investment and market entry:
Commercial feasibility studies for nanomedicines.
Validation of scalable manufacturing processes.
Support transitioning from preclinical development to launch.
Streamline regulatory compliance
Reduce time to market and meet global quality expectations:
Development of robust analytical methods for regulatory submission.
Quality assurance and GMP documentation aligned to compliance standards.
Secure strategic partnerships
Connect with the right people to move forward faster:
Access to nanomedicine specialists, manufacturers, and academic collaborators.
Stronger, more resilient supply chains for nano-formulations.
Partnerships to tackle industry-wide nanomedicine challenges.
How we support you
From discovery to commercialisation, we enable scalable, cost-effective, regulatory-compliant, and environmentally conscious pharmaceutical innovations.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
Demonstrate the benefits of your nanomedicine innovation
Accelerate early-stage development and build investor confidence with:
Rapid, cost-effective proof-of-concept studies.
Testing of nano-formulations in industry-relevant conditions.
Optimisation of nano-based drug delivery systems for performance and stability.
Prove manufacturability and scalability
De-risk scale-up through:
Manufacturability assessments of nanoparticle formulations.
Optimisation for yield, reproducibility, stability, and cost efficiency.
Integration of continuous processes and automation for clinical and commercial readiness.
Assess and demonstrate commercial viability
Gain the insight and evidence you need to unlock investment and market entry:
Commercial feasibility studies for nanomedicines.
Validation of scalable manufacturing processes.
Support transitioning from preclinical development to launch.
Streamline regulatory compliance
Reduce time to market and meet global quality expectations:
Development of robust analytical methods for regulatory submission.
Quality assurance and GMP documentation aligned to compliance standards.
Secure strategic partnerships
Connect with the right people to move forward faster:
Access to nanomedicine specialists, manufacturers, and academic collaborators.
Stronger, more resilient supply chains for nano-formulations.
Partnerships to tackle industry-wide nanomedicine challenges.
How we support you
From discovery to commercialisation, we enable scalable, cost-effective, regulatory-compliant, and environmentally conscious pharmaceutical innovations.
Demonstrate the benefits of your nanomedicine innovation
Accelerate early-stage development and build investor confidence with:
Rapid, cost-effective proof-of-concept studies.
Testing of nano-formulations in industry-relevant conditions.
Optimisation of nano-based drug delivery systems for performance and stability.
Prove manufacturability and scalability
De-risk scale-up through:
Manufacturability assessments of nanoparticle formulations.
Optimisation for yield, reproducibility, stability, and cost efficiency.
Integration of continuous processes and automation for clinical and commercial readiness.
Assess and demonstrate commercial viability
Gain the insight and evidence you need to unlock investment and market entry:
Commercial feasibility studies for nanomedicines.
Validation of scalable manufacturing processes.
Support transitioning from preclinical development to launch.
Streamline regulatory compliance
Reduce time to market and meet global quality expectations:
Development of robust analytical methods for regulatory submission.
Quality assurance and GMP documentation aligned to compliance standards.
Secure strategic partnerships
Connect with the right people to move forward faster:
Access to nanomedicine specialists, manufacturers, and academic collaborators.
Stronger, more resilient supply chains for nano-formulations.
Partnerships to tackle industry-wide nanomedicine challenges.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
How we support you
From discovery to commercialisation, we enable scalable, cost-effective, regulatory-compliant, and environmentally conscious pharmaceutical innovations.
Demonstrate the benefits of your nanomedicine innovation
Accelerate early-stage development and build investor confidence with:
Rapid, cost-effective proof-of-concept studies.
Testing of nano-formulations in industry-relevant conditions.
Optimisation of nano-based drug delivery systems for performance and stability.
Prove manufacturability and scalability
De-risk scale-up through:
Manufacturability assessments of nanoparticle formulations.
Optimisation for yield, reproducibility, stability, and cost efficiency.
Integration of continuous processes and automation for clinical and commercial readiness.
Assess and demonstrate commercial viability
Gain the insight and evidence you need to unlock investment and market entry:
Commercial feasibility studies for nanomedicines.
Validation of scalable manufacturing processes.
Support transitioning from preclinical development to launch.
Streamline regulatory compliance
Reduce time to market and meet global quality expectations:
Development of robust analytical methods for regulatory submission.
Quality assurance and GMP documentation aligned to compliance standards.
Secure strategic partnerships
Connect with the right people to move forward faster:
Access to nanomedicine specialists, manufacturers, and academic collaborators.
Stronger, more resilient supply chains for nano-formulations.
Partnerships to tackle industry-wide nanomedicine challenges.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
We are over 500 world-class innovation experts, scientists and engineers.
We are over 500 world-class innovation experts, scientists and engineers.
We are over 500 world-class innovation experts, scientists and engineers.
£3 billion of private investment unlocked
R&D projects delivered
Years of experience
Business collaborations
m² of facilities
Over £220m of innovation assets
£3 billion of private investment unlocked
R&D projects delivered
Years of experience
Business collaborations
m² of facilities
Over £220m of innovation assets
£3 billion of private investment unlocked
R&D projects delivered
Years of experience
Business collaborations
m² of facilities
Over £220m of innovation assets
Trusted by leading organisations
,
Why choose CPI?
Work with us to defer capital and workforce investments until your product or process is proven at scale.
Nanomedicine expertise
Proven success in formulation, characterisation, and scale-up.
Industry-leading infrastructure
Supporting full-scale nanomedicine manufacturing.
Collaborative approach
We connect you with industry partners, funding opportunities, and regulatory insights to de-risk your journey.
End-to-end support
From early-stage development to clinical trials.
Sustainable innovation
We support greener nanomedicine development through digital modelling, efficient continuous processes, and waste-reducing formulation strategies.
Regulatory and clinical readiness
From preclinical batches to GMP manufacturing for clinical trials, we help ensure your nanomedicine is ready for regulatory submission and real-world use.
Get in touch
Let's innovate together
At CPI, we understand that every innovation, manufacturing process, and application is unique. Our flexible engagement model builds custom projects around your goals.
Nanomedicines
Business Development
Get in touch
Let's innovate together
At CPI, we understand that every innovation, manufacturing process, and application is unique. Our flexible engagement model builds custom projects around your goals.
Nanomedicines
Business Development
Get in touch
Let's innovate together
At CPI, we understand that every innovation, manufacturing process, and application is unique. Our flexible engagement model builds custom projects around your goals.
Nanomedicines
Business Development
